The deaminase ADAR1 edits adenosines in nuclear transcripts of nervous tissue and is required in the fetal liver of the developing mouse embryo. Here we show by inducible gene disruption in mice that ADAR1 is essential for maintenance of both fetal and adult hematopoietic stem cells. Loss of ADAR1 in hematopoietic stem cells led to global upregulation of type I and II interferon-inducible transcripts and rapid apoptosis. Our findings identify ADAR1 as an essential regulator of hematopoietic stem cell maintenance and suppressor of interferon signaling that may protect organisms from the deleterious effects of interferon activation associated with many pathological processes, including chronic inflammation, autoimmune disorders and cancer.
that ADAR1 is involved in interferon-mediated immune responses to viral infection 1, 19 .
Disruption of Adar, the gene that encodes ADAR1, in mice leads to death at embryonic days 11.5-12.5 (E11.5-E12.5), in association with liver disintegration and defects in hematopoiesis 8, 9, 20 . Such findings are consistent with cell-intrinsic or secondary functions for ADAR1 in liver development and hematopoiesis. Here we report that ADAR1 is essential for the in vivo maintenance of the hematopoietic stem cell (HSC) and immature progenitor cell compartments in fetal liver and adult bone marrow. Moreover, we identify ADAR1 as a suppressor of interferon signaling in HSCs and progenitor cells in vivo.
RESULTS
Phenotypic HSCs are present in Adar -/-fetal liver To assess whether ADAR1 is required for the emergence of HSCs or their migration from production sites to the fetal liver 21 , we determined the immunophenotype and frequency of HSCs in the livers of E11.25 Adar -/-mice. We readily detected Lin -c-Kit + Sca-1 + (LKS + ) and Lin -AA4.1 + Sca-1 + (LAS + ) cells, which represent two HSC-enriched populations in fetal liver 22, 23 . The frequencies of these cells were appreciably higher in Adar -/-fetal liver than in wild-type and Adar +/-control fetal livers (Fig. 1) . However, the absolute number of HSCs in Adar -/-fetal liver was similar to that in controls as a result of less fetal liver cellularity (data not shown). In contrast, both the frequencies (Fig. 1a) and absolute numbers (data not shown) of Linc-Kit + Sca-1 -(LKS -) and Lin -AA4.1 + Sca-1 -(LAS -) progenitors were much lower in Adar -/-fetal liver than in controls. Adar -/-cells had greater intensity of Sca-1 surface expression and slightly lower intensity of c-Kit surface expression than did Adar +/-and wild-type © 2008 Nature Publishing Group http://www.nature.com/natureimmunology cells (Fig. 1b) . Detection of Lin -CD150 + CD48 -CD244 -cells, which represent a third HSC-enriched population 24, 25 , confirmed the presence of phenotypic HSCs in E11.0 Adar -/-fetal liver ( Supplementary  Fig. 1 online) . We concluded that ADAR1 is dispensable for the emergence of phenotypic HSCs and their migration to the fetal liver.
ADAR1 is required in fetal liver-derived HSCs
We next assessed possible involvement of ADAR1 in HSC function through inducible disruption of a conditionally deleted Adar allele 8 . To rule out the possibility that the cassette composed of the promoter of the gene encoding phosphoglycerate kinase driving expression of the neomycin-resistance gene (Pgk-neo r ) present in a previously generated Adar f7-9 allele (called 'Adar fn ' here) interfered with ADAR1 expression, we derived a version with deletion of Pgk-neo r by Cre recombinase-mediated excision in vivo (Adar f ; Supplementary  Fig. 2 online) . Adar f/f and Adar f/-mice, with the Adar f allele combined with the published 'Adar D2-13 ' null allele 8 (called 'Adar -' here) were viable and seemed healthy, whereas both Adar D/D and Adar D/-mice, with germline deletion of Adar (Adar D derived from the Adar f allele by Cre-mediated excision of the loxP-flanked Adar gene segment in vivo; Supplementary Fig. 2 ), recapitulated the embryonic-death phenotype of Adar -/-mice, as expected.
We interbred Adar f/-mice (Supplementary Fig. 2 ) with mice containing the Tg(Mx1-cre)1Cgn transgene 26 (called 'Mx1-Cre' here), which elicits efficient gene deletion throughout the hematopoietic system after administration of the interferon inducer polyinosinicpolycytidylic acid (poly(I:C)) 27, 28 . Untreated Adar f/-; Mx1-Cre mice were born at the expected mendelian frequency but, unexpectedly, died shortly after birth, possibly as a consequence of Adar deletion resulting from a small amount of Cre induction by endogenous interferon 28 ( Supplementary Fig. 3 online) . However, Adar f/-; Mx1-Cre embryos seemed mostly intact at E14.5, despite having slightly lower total fetal liver cellularity (data not shown).
To circumvent the unanticipated early death of untreated Adar f/-; Mx1-Cre mice, we did transplant studies with fetal liver-derived hematopoietic cells (Fig. 2a) . We distinguished donor and recipient cells in reconstituted wild-type mice using the CD45 congenic system 27, 28 in combination with Adar allele-specific PCR. At 5 weeks after transplantation, Adar f/-; Mx1-Cre fetal liver cells and Adar f/-and Adar f/+ ; Mx1-Cre control fetal liver cells had efficiently engrafted recipients and contributed multilineage peripheral blood cells ( Fig. 2b and Supplementary Fig. 4 online) . We then induced Mx1-Cre expression in the transplanted fetal liver-derived cells by administering poly(I:C). Notably, at 2 weeks after the first dose of poly(I:C), the contribution of Adar f/-; Mx1-Cre fetal liver-derived cells to peripheral blood leukocytes was diminished to one fourth that of control cells (Fig. 2b and Supplementary Fig. 4 ). The contribution of Adar f/-; Mx1-Cre cells to peripheral blood cells, including myeloid, B-lymphoid and T-lymphoid lineages, progressively decreased and was negligible by 23 weeks after treatment with poly(I:C); in contrast, the contribution of Adar f/-and Adar f/+ ; Mx1-Cre control cells was stable throughout the experiment (Fig. 2c) . Flow cytometry of bone marrow cells confirmed the loss of the contribution of Adar f/-; Mx1-Cre to many lineages noted in peripheral blood and showed very few, if any, donor-derived LKS + HSCs (Fig. 2d) . We obtained similar results when we identified donor-derived HSCs in the basis of the combined expression of SLAM cell surface receptors 24 (Fig. 2d) . Thus, the observed deficiency of HSCs was not caused by an alteration in their immunophenotype in response to the loss of ADAR1. These data demonstrate a cell-autonomous requirement for ADAR1 in fetal liverderived HSCs. We found no notable changes in the expression of genes associated with HSC maintenance in Adar -/-versus control Lin -CD150 + CD48 -CD244 -fetal liver HSCs ( Supplementary Fig. 5 online), which suggested a previously unknown mechanism by which ADAR1 regulates HSCs and immature hematopoietic progenitors.
ADAR1 is essential in HSCs of adult bone marrow
To study the in vivo consequences of ADAR1 loss in adult HSCs and to exclude the possibility of potential confounding effects of interferon induced by poly(I:C) in the context of ADAR1 deficiency, we interbred Adar f/-mice with mice carrying a tamoxifen-inducible transgene that mediates deletion of loxP-flanked alleles in HSCs (Tg(SCL6E5-Cre)1Jrg; called 'SCL-Cre-ER T ' here) 29 . In the absence of tamoxifen, Adar f/-; SCL-Cre-ER T mice (called 'Adar f/-.sc' mice here) and control mice seemed healthy and there was no detectable excision of the Adar f allele in peripheral blood ( Supplementary Fig. 6 online) . After inducing Adar f excision, we found quantitative deletion of Adar, as determined by PCR of genomic DNA, in peripheral blood cells of Adar f/+ .sc mice. In contrast, peripheral blood cells of Adar f/-.sc mice had only modest excision, a finding mostly consistent with in vivo selection against ADAR1-deficient cells ( Supplementary Fig. 6 ). Bone marrow analysis of Adar f/-.sc mice showed much lower cellularity than that of control mice (Fig. 3a) . Consistent with our findings in Adar -/-fetal liver (Fig. 1) , the frequency of LKS + cell-enriched HSC populations in Adar f/-.sc bone marrow was appreciably higher, whereas the frequency of LKS -progenitors was much lower, relative to that of induced and uninduced controls (Fig. 3a) . Hematopoietic progenitors from unfractionated Adar f/-.sc bone marrow yielded only colonies with the unexcised Adar f allele, whereas all colonies derived from Adar f/+ .sc bone marrow contained the excised allele (Fig. 3b) . 21, 30 . To gain insight into the events underlying the loss of ADAR1-deficient cells, we quantified the frequency of apoptotic cells in HSC-enriched LKS + and progenitor populations in the bone marrow of Adar f/-.sc and control mice. The number of apoptotic cells in resting LKS + and LKS -populations with characteristic low expression of the integrin Mac-1 (CD11b) 31 in the bone marrow of induced Adar f/-.sc mice was only slightly higher than that of control mice ( Supplementary Fig. 7 online) . In contrast, 68% of cycling (Mac-1-expressing) HSCs in Adar f/-.sc bone marrow were apoptotic, compared with 3-13% in control bone marrow, as determined by annexin V staining (Fig. 3c) . These observations are most consistent with a requirement for ADAR1 in cycling HSCs, although our data do not exclude the possibility that Mac-1-expressing immature progenitors 32 contributed to the apoptotic population. Notably, the frequency of apoptotic cells was positively correlated with surface expression of Sca-1; that is, the number of apoptotic cells was highest in the c-Kit + Sca-1 hi population (data not shown). The few detectable LKSprogenitors in the bone marrow of Adar f/-.sc mice did not show more apoptosis, consistent with our finding that all in vitro colony-forming activity of hematopoietic progenitors in Adar f/-.sc bone marrow was derived from cells that contained the unexcised Adar f/-.sc allele (Fig. 3b) . In support of a requirement for ADAR1 in cycling HSCs, cell cycle analysis showed many more S-phase cells in the LKS + CD34 hi short-term HSC population of Adar f/-.sc bone marrow than in that of Adar f/+ .sc bone marrow (Fig. 3d) , which perhaps reflected activation in response to pancytopenia (Supplementary Table 1 is not a general property of blood cells or stem cells, as we found ADAR1 to be dispensable for the myeloid lineage (J.C.H., C.R.W. and S.H.O., unpublished data), for embryonic stem cell self-renewal and embryoid body formation in vitro (J.C.H., unpublished data), and for the contribution to adult tissues of all three germ layers in chimeric mice, except hematopoietic tissues and liver 8 . Conversely, disruption of Adar in the erythroid lineage caused loss of erythroblasts in the fetal liver (J.C.H. and S.H.O., unpublished data), which indicated that the requirement for ADAR1 is not restricted to uncommitted hematopoietic progenitors.
ADAR1 deficiency elicits a global interferon response
To elucidate the molecular mechanisms underlying the requirement for ADAR1 in HSCs, we determined the relative expression of constitutively expressed ADAR1 p110 and interferon-induced ADAR1 p150 transcripts (Fig. 4a ) in sorted LKS populations from wild-type mice by real-time PCR (Fig. 4b) . The p150 transcripts were much more abundant than p110 transcripts in all LKS populations. Consistent with the hypothesis that p150 is the crucial isoform in HSCs, embryonic stem cells, in which ADAR1 is dispensable, expressed the p110 transcript almost exclusively (Fig. 4b) . Given the predominant expression of the interferon-induced p150 transcript, we considered the possibility that the requirement for ADAR1 involves pathways activated by interferon in HSCs.
Sca-1 is expressed from an interferon-inducible gene 33 . We reasoned that the unexpected death of uninduced Adar f/-; Mx1-Cre pups and the higher surface expression of Sca-1 on Adar -/-LKS + cells than on wild-type and Adar +/-LKS + cells (Fig. 1b) might have reflected activation of the interferon pathway in response to ADAR1 loss. We tested our hypothesis by genome-wide transcriptome analysis in Adar -/-and control fetal liver HSCs purified on the basis of SLAM marker expression 25 (Supplementary Figs. 1 and 9 online). Gene setenrichment analysis 34 , a powerful computational method that determines statistically significant differences between gene sets obtained from microarray data, showed a strong association between ADAR1 © 2008 Nature Publishing Group http://www.nature.com/natureimmunology deficiency and the gene expression 'signatures' of interferon-treated or virus-infected cells ( Fig. 4c and Supplementary Fig. 10 and These findings hint at cell-specific differences in how ADAR1 participates in regulation of interferon signaling. Given that ADAR1 is a dsRNA-binding and dsRNA-processing protein and that ADAR1 deficiency might lead to an interferon response induced by intracellular dsRNA resulting from an unknown ADAR1-dependent mechanism, we examined our expression data set for transcripts that have been shown experimentally to be inducible by dsRNA 35 . Among those, only transcripts known to be inducible by interferon were substantially upregulated in ADAR1-deficient HSCs relative to their expression in wild-type and Adar +/-control HSCs ( Supplementary Fig. 11a online) . Likewise, among transcripts encoding known dsRNA-binding proteins, only those expressed from interferon-inducible genes, such as those encoding PKR (EIF2AK2), IFIH1 (RIG-1) and TLR3, were upregulated in ADAR1-deficient HSCs relative to their expression in control HSCs ( Supplementary  Fig. 11b ). The dsRNA-binding protein NF90 has been shown to interact with ADAR1 (ref. 36) . Notably, the Adar -/-'signature' was associated with profiles obtained from cells that express or overexpress a carboxy-terminal variant of NF90 protein 37 ( Supplementary Fig. 12 and Table 2 online), which suggested a functional link between NF90 and ADAR1.
To examine whether the interferon response to Adar deletion is unique to hematopoietic cells, we used quantitative PCR to analyze the expression of interferon-inducible transcripts in early-E11 Adar -/-embryos that had had their livers removed ( Supplementary  Fig. 13a online) . Similar to our observations of HSCs and erythroid cells, we found considerable upregulation of interferon-inducible transcripts in these embryos relative to their expression in control embryos. Enzyme-linked immunosorbent assay for interferon showed that the extracellular fluid of Adar -/-embryos had over 13-fold more interferon-a (IFN-a) and over 80-fold more IFN-b than did control embryos; IFN-g was not detectable in either group ( Supplementary  Fig. 13b) . expression in the extracellular fluid of dying embryos deficient in the transcription factor GATA-2 (data not shown). GATA-2 deficiency causes loss of immature hematopoietic progenitors in the fetal liver and embryonic death by about E11 (ref. 38 ). Thus, ADAR1 deficiency leads to a widespread failure to appropriately regulate an interferon response in the embryo that may be caused or enhanced by paracrine activities of type I interferons secreted into the extracellular fluid from fetal liver HSCs and erythroid cells after activation of their interferon system. Our findings collectively identify ADAR1 as a regulator of HSC maintenance and suggest a model in which ADAR1 is dispensable for the emergence of long-term reconstituting HSCs and, perhaps, their self-renewal activity. However, ADAR1 becomes essential for the survival of HSCs as they progress to the multipotent progenitor stage, a process associated with downregulation of Sca-1 surface expression ( Supplementary Fig. 14 online) .
DISCUSSION
In addition to our finding that ADAR1 is essential for maintenance of hematopoiesis in the fetal liver and adult bone marrow, we have identified ADAR1 as an essential suppressor of interferon signaling. Stringent control of this pathway, which is involved in many physiological processes, including inflammation and the innate immune response, is needed to prevent the deleterious effects of excessive interferon activation. Defective interferon signaling has been associated with various pathological conditions, such as chronic inflammation, autoimmune disorders and cancer. The loss of HSCs and immature progenitors in the absence of ADAR1 was most likely a consequence of a failure to hold interferon activation in check.
Conversion of adenosine to inosine in nuclear transcripts is the only established function of ADAR1. Therefore, it is plausible that ADAR1 regulates interferon signaling by editing crucial, presently unknown transcripts. However, given the complexity of the interferon pathway and its activation by many stimuli, it is instructive to consider alternative possibilities. First, because ADAR1 is a dsRNA-binding protein and the innate immune response to dsRNA involves the activation of type I interferons 35 , we examined our expression data for genes induced by dsRNA. Indeed, a gene set obtained from cells treated with dsRNA was associated with the Adar -/-'signature' in that interferon-induced genes were considerably upregulated. ADAR1 deficiency enhanced the expression of transcripts encoding the interferon-inducible dsRNA-binding proteins PKR (EIF2AK2), IFIH1 (RIG-1) and TLR3, whereas the expression of transcripts for other dsRNA-binding proteins was not appreciably altered. Those observations suggest that immunoreactive dsRNA resulting from the failure of an unknown ADAR1-dependent process contributes to the interferon response induced by ADAR1 deficiency. Second, ADAR1 has been shown to interact with the dsRNA-binding protein NF90 through dsRNA and enhance NF90-mediated expression of genes, including that encoding IFN-b, in a way independent of RNA editing 36 . The Adar -/-'signature' is associated with profiles obtained from cells that express or overexpress a carboxy-terminal variant of NF90 protein 37 , which raises the possibility that ADAR1 deficiency disrupts ADAR1-containing protein complexes involved in the regulation of interferoninduced gene expression. Third, a study has suggested involvement of ADAR1 in a cell-intrinsic DNA-sensing mechanism that involves the putative Z-DNA-binding protein DAI, a sensor for cytosolic DNA 39 . Consistent with possible involvement of ADAR1 in intracellular DNAsensing pathways, the abundance of DAI transcripts was 15-fold greater in Adar -/-HSCs than in control HSCs (data not shown). Finally, another study has suggested that transcriptional activation of human IFNB mediated by the transcription factor NF-kB after viral infection involves the use of NF-kB-binding sites embedded in an Alu repeat 40 . Notably, widespread A-to-I editing of Alu repeat-containing mRNA has been described in humans [2] [3] [4] the expression of interferon-inducible genes by targeting regulatory elements embedded in Alu or Alu-like repeats. Additional work is needed to elucidate whether ADAR1 is directly involved in the regulation of interferon signaling, such as by editing crucial transcripts of protein-coding or regulatory RNA genes, or whether activation of the interferon pathway by ADAR1 deficiency represents a cellular response to immunoreactive nucleic acids that may result from failure of an unknown ADAR1-dependent mechanism. Independent of the underlying mechanism, our study has identified ADAR1 as an essential in vivo suppressor of interferon-induced gene expression. Our finding that ADAR1 was essential during the activated state of a rare cell population that constitutes less than 0.05% of total bone marrow may explain, in part, why intensive efforts in the past have been unable to identify crucial targets of ADAR1. Without substantial enrichment of specific, rare cells, the search for low-abundance or edited transcripts may prove unsuccessful. Identifying the targets of ADAR1, which may include protein and nonprotein coding transcripts, or possibly interacting proteins 36 , is crucial for fuller understanding of the unanticipated requirements for ADAR1 in the maintenance of hematopoiesis and suppression of interferon signaling.
METHODS
Experimental mice. All mice were backcrossed at least six times to the C57BL/6 strain from a C57BL/6-Sv129 hybrid background. Adar f mice (with loxPflanked Adar) were derived from crosses of Adar fn mice 8 with several transgenic Cre recombinase-expressing mouse lines and were selected by genomic PCR for recombination events that had excised the Pgk-neo r cassette from the Adar f allele without deleting the loxP-flanked Adar segment ( Supplementary Fig. 2 ). Pups that transmitted the Adar f allele through the germline were identified by Cre transgene-specific PCR of genomic DNA after elimination of the Cre transgene by breeding of Adar f . Cre mice with mice lacking the Cre transgene and selection for offspring lacking the Cre transgene. Transgenic Mx1-Cre mice 26 and SCL-Cre-ER T mice 29 have been described. Experiments were done with the approval of the animal ethics committees of Dana-Farber Cancer Institute and Children's Hospital Boston.
Genotyping. All mice and tissues were genotyped by genomic PCR. Adarmutant mice and tissues were genotyped as described 8 . For genotyping of Mx1-Cre mice, Mx1-Cre-specific oligonucleotides were designed (5¢-CAATATCG ATTTCCCAACCTCAG-3¢ and 5¢-CTTGCACCATGCCGCCCACGAC-3¢). The identity of the amplicon was confirmed by DNA sequencing. SCL-Cre-ER T mice were genotyped as described 29 .
Flow cytometry. Cells were processed and analyzed on a FACSCalibur (BD) or were sorted on a FACSAria (BD) as described 41, 42 . Lineage depletion, preceded by density centrifugation with Ficoll-Paque Plus (GE Healthcare Life Sciences), was done with biotin-conjugated antibodies and fluorochrome-conjugated streptavidin (eBioscience) or with magnetic beads as described by the manufacturer (Dynal) with affinity-purified rat antibodies to mouse lineage (eBioscience). The lineage-depletion 'cocktail' included antibody to CD4 (anti-CD4; GK1.5), anti-CD5 (53-7.3), anti-CD8a (53-6.7), anti-B220 (RA3-6B2), anti-Gr-1 (RB6-8C5), anti-Mac-1 (M1/70) and anti-Ter119 (TER-119). For recovery of fetal liver or activated bone marrow HSCs, anti-Mac-1 was omitted from the 'cocktail' . Lineage-depleted fetal liver HSCs and multipotent progenitors were analyzed with anti-c-Kit (2B8) and anti-Sca-1 (E13-161.7), or anti-Sca-1 and anti-C1qRp (AA4.1), or sorted with antibodies to the SLAM proteins CD150 (TC15-12F12.2), CD48 (HM48-1) and CD244 (eBio244F4; all antibodies from eBioscience).
Long-term reconstitution. Fetal livers dissected from live E14.5 embryos were genotyped by genomic PCR and single-cell suspensions were prepared. Live cells, identified by exclusion of Trypan blue dye (Invitrogen), were counted in a Neubauer hemocytometer. Equivalent numbers of cells from two or three fetal livers of each genotype were pooled, and 3 Â 10 6 live cells in 0.2 ml sterile PBS were noncompetitively transplanted into irradiated CD45.1 recipients (given 5.25 Gy twice, 3 h apart). Cre expression was induced by intraperitoneal injection of poly(I:C) (Sigma) as described 28, 41, 42 . The contribution of donor cells to the peripheral blood was monitored by donor-specific flow cytometry and PCR of genomic DNA.
Tamoxifen administration. Mice 12-20 weeks of age were injected intraperitoneally with 2 mg tamoxifen in 0.2 ml corn oil per day per mouse or were fed a standard mouse chow supplemented with tamoxifen at 1 g per kg chow (Research Diets).
Methylcellulose culture. Bone marrow cells (1.25 Â 10 4 cells) were cultured in duplicate in MethoCult M3434 medium (Stem Cell Technologies) and colonies were assigned scores by microscopy. For single-colony PCR, individual colonies were picked and washed in PBS and genomic DNA was isolated with a QIAamp DNA Blood Mini kit as directed by the manufacturer (Qiagen).
Apoptosis. Lineage-depleted bone marrow cells were stained with fluorochrome-conjugated anti-c-Kit (2B8) and anti-Sca-1 (E13-161.7), annexin V protein and 7-amino-actinomycin D (1 mg/ml; Molecular Probes), followed by analysis on a FACSCalibur (BD Biosciences) as described 42 .
Cell cycle analysis. Live, lineage-depleted bone marrow cells were stained with fluorochrome-conjugated anti-c-Kit (2B8), anti-Sca-1 (E13-161.7) and anti-CD34 (RAM34) and were processed for cell cycle analysis as described 43 . Cells (3 Â 10 5 ) were analyzed on a FACSAria equipped with an ultraviolet laser (BD Biosciences). Data were analyzed with FlowJo software (TreeStar).
Gene expression profiling. Live CD150 + CD48 -CD244 -HSCs (5 Â 10 2 to 15 Â 10 2 cells per fetal liver) were isolated by flow cytometry from individual, viable early-E11 embryos. Total RNA was extracted with a microRNA kit (Qiagen), was reverse-transcribed and was amplified with the WT-Ovation Pico RNA amplification system. Single-stranded cDNA amplification products were purified with a DNA Clean-up & Concentrator kit (Zymo Research) and were labeled with an FL-Ovation cDNA Biotin Module V2 (NuGEN Technologies). Transcriptome analysis was done with GeneChip Mouse Genome 430 2.0 arrays (Affymetrix) at the Broad Institute. Data were normalized with the RMA algorithm of GenePattern software (Broad Institute). Gene set-enrichment analysis (Broad Institute) was then done with the curated gene set collection C2 in the Molecular Signatures database for distinction of Adar -/-HSCs versus Adar +/+ and Adar +/-HSCs. Gene sets were filtered to eliminate those with less than 15 or over 800 genes, which resulted in a total of 1,247 gene sets. The dataset was row-normalized before being subjected to gene set-enrichment analysis with signal-to-noise measurement and 30,000 permutations on the genes. For hierarchical clustering, expression data were filtered to eliminate genes with maximum expression values of under 100 in all samples, with a s.d. over mean of less than 0.5 and with present call percentage of less than 20% of samples. Data were then log 2 -transformed and clustered with Pearson correlation measurement and average linkage.
Real-time PCR. Live HSCs and progenitors were isolated by flow cytometry from the femora, tibiae and ilia of ten male C57BL/6 mice (12 weeks old) or from livers of viable, individual early-E11 embryos. Total RNA was extracted with a microRNA kit (Qiagen), and a SuperScript III system (Invitrogen) was used for random hexamer-primed cDNA synthesis as recommended. For samples containing less than 5 Â 10 3 cells, total RNA was reverse-transcribed and amplified with a WT-Ovation Pico RNA amplification system (NuGEN Technologies) as described above. Real-time PCR was done in duplicate with iQ SYBR Green Supermix in combination with the iQ5 real-time PCR detection system (Bio-Rad). Adar-specific oligonucleotides for real-time PCR were designed on the basis of sequence information obtained by analysis of RNA by 5¢ rapid amplification of cDNA ends, for total RNA isolated from embryonic stem cells and mouse embryonic fibroblasts with TRIzol reagent (Invitrogen; oligonucleotide sequences, Supplementary Table 4 online). Expression of mRNA expression was normalized to that of Ywhaz (encoding tyrosine 3-monooxygenase-and tryptophan 5-monooxygenaseactivation protein, z-polypeptide; GenBank accession number, 22631), Ppia (encoding peptidylprolyl isomerase A) or Gapdh (encoding glyceraldehyde phosphate dehydrogenase) mRNA by analysis of the change in cycling threshold (DDC T method).
Interferon enzyme-linked immunosorbent assay. Cell suspensions from live early-E11 embryos were prepared in ice-cold PBS and were centrifuged at a moderate speed, and interferon protein concentrations in the cell-free supernatant were quantified with enzyme-linked immunosorbent assay kits for IFN-a, IFN-b and IFN-g as directed by the manufacturer (R&D Systems). Data were acquired on a Benchmark Plus microplate spectrophotometer and were analyzed with Microplate Manager III software (Bio-Rad).
Statistics. The statistical significance of differences in means was calculated with an unpaired t-test, unless otherwise indicated. P values of less than 0.05 were considered statistically significant.
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